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Are tyrosinase, encoded at the albino locus, and tyrosinase-re.: 
lated protein-l (TRP-l ), encoded at the brown locus, simi-
larly distributed in melanocytes? We determined the subcel-
lular distribution of tyrosinase and TRP-l using density 
fractionation of postnuclear supernatants from mouse mela-
noma cells of defined genotype followed by immunoblotting 
with specific antipeptide sera. In highly melanized cells, the 
majority of tyrosinase cosedimented on Percoll density gra-
dients with visible melanin and with the peak of DOPA 
incorporation, confirming its presence predominantly in 
stage III - IV melanosomes. In contrast, the distribution of 
TRP-l was limited to a less-dense melanosomal compart-
ment, devoid of melanin. In amelanotic or minimally melan-
ized cells, the majority of tyrosinase shifted into these lighter 
peaks. To explore a suspected relationship between lyso-
somes and melanosomes, we analyzed the distribution of 
lysosome-associated membrane protein-l (LAMP-l). An 
M elanin is a biopolymeric pigment synthesized by melanocytes. The particulate nature of tyrosinase, the key enzyme of the melanin synthetic rath-way, was recognized more than 40 years ago 1,2]' Using the electron microscope (EM) and newly 
developed methods for subcellular fractionation, the site of melanin 
deposition was identified and termed the melanosome [3]. Much of 
what is known regarding the melanosome derives from electron 
microscopy. 
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Abbreviations: 
DMEM: Dulbecco's modified Eagle's medium 
EM: electron microscope 
IBMX: isobutylmethylxanthine 
IPB: immunoprecipitation buffer 
LAMP-1: lysosome-associated membrane protein-1 
MSH: melanocyte-stimulating hormone 
PBS: phosphate-buffered saline 
PTU: phenylthiourea 
SDS-PAGE: sodium dodecylsulfate-polyacrylamide gel electropho-
resis 
TGN: trans-Golgi network 
TRP-1: tyrosinase-related protein-1 
overlap in the distribution of LAMP-l and TRP-l was dem-
o?stra~ed by immunomicroscopy and confirmed by immun-
Olsolatlon. LAMP-l was not present in the dense, melanin-
rich melanosomal peak on gradient analysis. 
TRP-l from melanoma cells homozygous for the brown 
mut~tion i~ not ~ull'y glyco.syla~ed, is more rapidly degraded, 
and is restncted III its dlstnbutlOn compared to its wild-type 
counterpart. In these mutant cells, all melanosomal compart-
ments contain LAMP-l. 
Our results demonstrate that in wild-type cells the major-
ity of tyrosinase eventually localizes to stage III - IV melano-
somes. TRP-l is limited to a less dense melanosomal com-
partment that is also LAMP-l positive. The existence of this 
compartment suggests that it may represent a common step in 
the biogenesis of melanosomes and lysosomes. ] Invest Der-
matol1 00:55 - 64, 1993 
Four successive stages in the maturation of the melanosome have 
been delineated, from stage I, the "premelanosome", a spherical 
vac~ole ~ith absent or ill-defined matrix filaments, through Stage 
II, m whlch the melanosome. assumes the elliptical shape with a 
well-defined filam~ntous matrlX, stage III, with deposition of elec-
tron opaque mela11ln on these filaments, and, finally, stage IV with 
complete opacification of melanosomal contents by melanin '[4]. 
Tyrosinase is a copper-binding glycoprotein ofMr 75000 which 
cataly~e~ three steps in the syn~hesis of.~elanin [2,5,6] . eyto'chemi-
cal stammg for the DO P A oXldase aCtiVity of tyrosinase reveals the 
presence of the enzyme in the trans-Gol.gi network (TGN) or reticu-
lum (an area of the cell that was prevlOusly described as "smooth 
endoplasmic reticular extensions" or "GERL"), in a population of 
coated vesicles, as well as in pre- and/or sta?e II melanosomes [7-
10]. The most commonly accepted explanation for this observation 
involves a bipartite pathway for melanosomal biogenesis. First, 
"premelanosomes" containing incompletely organized matrix bud 
from the TGN, and the matrix subsequently condenses into its 
readily recogniza~le form (stageJr mela.nosome). Concurrently or 
subsequently, veSicles that contam tyrosmase arise from the TGN. 
Fusion of these vesicles with the Stage II melanosomes is believed to 
initiate the process of melanogenesis [4]. Purification of subsets of 
vesicles from activel~ melanizing m.elanoma cells reveals that they 
have the expected high concentration of tyrosinase and melanin 
intermediates within them [11-13]. 
A second glycoprotein known to playa role in melanogenesis is 
the product of the brown (b) locus, a glycoprotein of Mr 75000 that 
is 43% identical to tyrosinase at the amino acid level; the pr~tein has 
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been named tyrosinase-related protein-1 (TRP-1) [14,15]. Al-
though melanin is normally black in wild-type (BIB) mice, mice 
homozygous for the recessive brown mutation (bib) are brown. 
Electron microscopic studies reveal that the "brown" melanosome 
is more spherical, and its melanin more flocculently deposited than 
in wild-type "black" melanosomes [16]. We have recently shown 
that melanin from BIB mice is black and insoluble at physiologic 
pH, whereas that from brown (bib) mice is both soluble and brown 
under the same conditions [17]. Due to its homology to tyrosinase, 
it has been widely assumed that TRP-1 is distributed in melano-
somes, just like tyrosinase [18-20] . 
A relationship between Iysosomes and melanosomes has long 
been suspected. Lysosomal enzymes are shuttled from the TGN to 
lysosomal precursors via a subset of coated vesicles [21]. The pres-
ence of acid phosphatase, a well-described marker for Iysosomes and 
certain other TGN-derived secretory organelles, has been demon-
strated in melanosomes by histochemical means [22,23]. A number 
of autosomal recessive mutations in the laboratory mouse affect 
both coat color and ocular pigmentation, as well as the secretion of 
lysosomal hydro lases or lysosomal structure [24,25]. 
To gain a better understanding of the dynamic subcellular proc-
esses involved in the biogenesis of the melanosome, and to investi-
gate the relationship between melanosomes and Iysosomes, we initi-
ated the studies described here. We utilized the ability to 
manipulate the state of pigmentation, and of melanosomal matura-
tion, of two cultured mouse melanoma cell lines of defined geno-
type (B16 and Cloudman S91) by the use of hormonal and pharma-
cologic agents [26 - 28]. As markers for membrane glycoproteins 
involved in melanogenesis, we have analyzed the subcellular distri-
bution of tyrosinase and TRP-1 by subcellular fractionation, im-
munomicroscopy, and immunoisolation of organelles. 
Our results suggest that the distributions of tyrosinase and TRP-1 
in melanocytes are not identical, and that there is an early or "pre-
melanosomal" compartment that contains proteins destined for mel-
anosomes as well as Iysosomes. 
MATERIALS AND METHODS 
Cell Culture B 16 melanoma cells (wild-type genotype BIB, ob-
tained from Dr. J.c. Bystryn, New York University) were cultured 
in Dulbecco's modified Eagle's medium (DMEM) containing 10% 
fetal calf serum, 1 % nonessential amino acids, and penicillin and 
streptomycin. Cloudman S91 melanoma cells (homozygous reces-
sive genotype bib, obtained from Dr. J. Pawelek, Yale University) 
were cultured as described previously [27]. Treatment of cells with 
melanocyte-stimulating hormone (MSH) and isobutylmethylx-
anthine (IBMX) and culture ofB 16 cells in AIM V synthetic serum-
free medium (purchased from GIBCO [Grand Island, NY]) were as 
described [27,28] . 
We have recently shown that culture of B16 cells in AIM V 
medium causes a 10-50 fold, time-dependent stimulation of me-
lanization by this cell line, associated with acquisition of a spheroi-
dal cell morphology and loss of attachment to the substratum [28]. 
Subcellular Fractionation Cells were removed from culture 
dishes by scraping with a rubber policeman into 1 ml of phosphate-
buffered saline (PBS) containing 10% glucose and 10 ,ug/ml apro-
tinin and leupeptin. The volume was then adjusted to 3.5 ml with 
0.25 M sucrose, 10 mM HEPES, pH. 7.2, and 1 mM EDTA. Ho-
mogenization was performed with 15 strokes of a Dounce homo-
genizer on ice. Cell breakage was assessed by trypan blue exclusion. 
A postnuclear supernatant was mixed with 90% Percoll in 0.25 M 
sucrose buffer to a final concentration of 28% Percol!. The sample 
was centrifuged in a VTi 65.2 rotor for 48 min at 10,000 X g at 
4 0 C. Two-hundred-fifty -microliter samples were collected from 
the bottom of the centrifuge tubes with the aid of a peristaltic pump. 
Immunoblotting Aliquots from gradient fractions were re-
moved, mixed with SDS-sample buffer containing mercaptoeth-
anol, boiled, and subjected to sodium dodecylsulfate -
polyacrylamide gel electrophoresis (SDS-PAGE) in 7.5% 
polyacrylamide gels followed by transfer to polyvinyledene diflour-
ide membranes (Immobilon-P, Millipore, Waltham, MA). Rain-
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Figure 1. Subcellular distribution of tyrosinase, TRP-l. and LAMP-1. (A -
C) Postnuclear supernat.ants of B16 melanoma cells (BIB genotype) were 
subjected to Percoll gradient density centrifugation. Fractions were collected 
and ~naly~ed as noted below. In each case the bottom of the gradient (densest 
f~actlOns) IS at the left: and the top of the gradient (lightest fractions) is on the 
right. Tyroslllase actlVlty (e) was quantitated by radiometric assay; TRP-l 
(D) and LAMP-l ~~) were quantitated by immunoblotting followed by 
computerlz~d denSitometry. Tyrosinase activity is shown on the left axis as 
CPM of tritiated water released. Note that the numbers for (C) are in 
tho.usands. In the case ofTRP-l and LAMP-l, the right-hand axis denotes 
arbItrary Ulllts. (A) Non~lgmented cells;. (B) lightly pigmented cells (stimu-
lated ~Y 3 d of growth m AIM V medIUm); (C) cells induced to heavily 
melalllze (by growth for 10 d in AIM V medium). One-fourth the number 
of ce.ll was used to ~enerate. the data in (C) compared to (A) and (B) . The 
dlStnb~tlon of tyrosmase shifts from Peak I to Peak II to peak III as melani-
zation mcreases, whereas the distribution ofTRP-l and LAMP-l does not 
change. 
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Figure 2. Subcellular distribution of melanin deposition. B16 cells grown 
for 10 d in AIM V medium (as in Fig 1e) were incubated with .4C DOPA as 
described in Materials at.d Methods and subjected to Percoll density gradient 
analysis (e). Duplicate cultures were also treated with 0.25 mM PTU (l:» to 
inhibit tyrosinase-driven incorporation of DOPA into melanin. 
bow Markers (Amersham, Arlington Heights, IL) were run as mo-
lecular-weight markers. Nonspecific sites were blocked by incuba-
tion of membranes in 3% (w /v) nonfat dry milk in PBS. The follow-
ing antisera were used at the indicated dilutions: a-PEPI (1: 500) 
(directed against a carboxy-terminal epitope of TRP-l), a-PEP2 
(1: 200) (directed against an amino-terminal epitope of TRP-l), 
a-PEP7 (1: 200) (directed against a carboxy-terminal epitope of tyr-
osinase) [all from Dr. V. Hearing, NCI (29»); a-LAMP-l (1: 100) 
(directed against an intraluminal epitope of LAMP-l) [obtained 
from the NICHHD Developmental Studies HybridomaBank, Uni-
versity of Iowa (30»); and normal rabbit serum (1 : 100). In the case 
of aLAMP-l , a rat monoclonal antibody, a second incubation with 
rabbit anti-rat IgG serum (Sigma Chemical Co., St. Louis, MO) 
(1: 1000) was performed. After washing six times with PBS con-
taining 0.05% Tween-20, incubation with 1251 Protein A (ICN, 
Costa Mesa, CA; 0.1.uCi/ml) in PBS/milk was performed. Follow-
ing an additional six washes, the dried membrane was subjected to 
autoradiography with Kodak XAR5 film with a Dupont Cronex III 
screen at - 70 °C . 
Metabolic Labeling and Immunoprecipitation Cells were 
t reated with or without MSH/IBMX for 24 h prior to labeling. 
Culture medium was replaced with methionine-free Ham's F-lO 
containing 10% horse serum (which had been dialyzed against 
PBS). If cells had been treated with a pharmacologic agent, this was 
included in the culture medium, as well. After 60 min at 37"C to 
allow depletion of intracellular methionine pools, Translabel (a 
mixture of 70% 35S-methionine and 15% 35S-cystine, S.A. 1187 
Ci/mmol; ICN, Irvine, CA) was added at 100 .uCi/ml and incuba-
tion at 37°C continued for 10 min. The cells were washed rapidly 
with complete medium and fresh complete medium ("chase") was 
added for the indicated times. In the experiment detailed in Fig 6, 
cells were treated with the following concentrations of glycosyla-
tion inhibitors: tunicamycin (20.ug/ml), swainsonine (l.ug/ml), 
and deoxymannojirimycin (1 mM). Incubation was for 1 h with 
drug. Radioactive label was then added for 45 min . The medium 
was then replaced with fresh medium containing excess unlabeled 
methionine and the appropriate drug. Cells were washed twice with 
PBS and then solubilized for 10 min on ice with immunoprecipita-
tion buffer (IPB) containing 50 mM Tris-HCJ, pH 7.4, 150 mM 
NaCI,2 mM EDTA, and 1 % Triton X-I00. Extracts were cleared 
by centrifugation at 8800 Xg for 10 min. 
Extracts were precleared by the addition of 1 0 ,ul of normal rabbit 
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serum followed by lOO.u1 of a 30% suspension (v Iv) of Protein 
A-Sepharose. After 60 min 011 ice, the sepharose was removed by 
c~ntrifugation, and a fresh aliquot added. After a final centrifuga-
tion, the extract could be used for immunoprecipitation. Prior to 
immunoprecipitation, the number of TCA-precipitable counts in-
corporated was determined, and an equal number ofTCA-precipita-
ble counts (typically 5 X 106) were used to compare extracts. 
Antiserum or preimmune serum (3 .ul) were added to the pre-
cleared extracts, followed by a 4-h incubation on ice. Volumes were 
adjusted to O.S ml with IPB. T wenty microliters of Protein A-
Sepharose (30% suspension) were then added. One hour lat er, the 
Protein ~-~ephar?se was removed by brief centrifugation and 
washed SIX ~I~nes With IPB and.once with PBS. Immunoprecipitates 
were solubilIzed by t~~ additIOn ~f 50.u1 of SDS-PAGE loading 
buffer, followed by. bOllmg for 1 mm. They were then subjected to 
SDS-PAGE analYSIS on 7.5% polyacrylamide gels. After fixation 
and staining, gels were immersed in Amplify (Amersham), dried, 
and exposed to HyperfilmECL (Amersham) at-70°C. The molec-
ular-weight !narkers used were myosin (200 kd), phosphorylase 
(97 kd), bovme serum albumin (68 kd) , ovalbumin (45 kd) , and 
carbonic anhydrase (31 kd). 
Immunoisolation with Magnetic Beads Cells were broken as 
for subcellular fractionation, and a P?stnuclear supernatant pre-
pared. The procedure was an adaptation of previously described 
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Figure 3. Coisolation of TRP-l and LAMP-l. Immunoisolatio . 
. b d d ' I h '. . . n usmg 
magnetic ea s coate Wit 1 t e mdlcated antisera was carried OUt as de-
scribed in. Materials alld Methods. Following immunoisolation, beads were 
treated With SDS-PAGE sample buffer, and eluted proteins subjected to 
50S-PAGE and transferred to nyloll sheets. Immunoblotting with the indi-
cated antls~ra was then performed. Note that only beads coated with aPEP-
1, the antibody to the exposed cytoplasmic tail of TRP-l, are capable of 
Immul101s01atmg an organelle containing both TRP-l (closed arrow) and 
LAMP-l (ope/) arrow) . 
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methods [31]. Supernatants made to 3% nonfat dry milk (from a 
20% stock) were "precleared" with goat anti-rabbit-IgG-coated 
magnetic beads (Advanced Magnetics, Cambridge, MA) (which had 
been previously coated with normal rabbit serum) by use o~ a mag-
net (Advanced Magnetics), followed by a second preclearmg step 
using Protein A - magnetic beads (Advanced Magnetics), also pre-
coated with normal rabbit serum. The "precleared" supernatant was 
then allowed to react with Protein A beads (precoated with the 
appropriate sera) for 2 h on ice on a rocker, and then washed with 
the use of the magnet six times with PBS. Beads were exposed to 1 % 
SDS to elute bound proteins, SDS-PAGE sample buffer was added 
to the eluate, and the eluate was subjected to SDS-PAGE, followed 
by transfer to Immobilon-P membranes. Immunoblotting was per-
formed as described above. 
Tyrosinase Assay Fifty-microliter fractions from Percoll gra-
dients were added to an equal volume of 0.1 M sodium phosphate 
buffer (pH 6.8) containing 1 % Triton X-I00, and were then assayed 
for tyrosinase activity by a radiometric assay [26,27] adapted from 
that originally described by Pomerantz [32]. The assay measures the 
release oPHzO upon the hydroxylation of tyrosine by the enzyme. 
He DOPA Incorporation To detect the site of active melanin 
deposition, cells were incubated overnight in culture medium sup-
plemented with 14C DOPA labeled in the 3-position (specific activ-
ity 4.85 mCi/mmol; Amersham) at 1.21lCifml followed by a I-h 
"chase" in normal medium to remove any of the isotope that had 
not been incorporated into macromolecular material. Subcellular 
fractionation was performed on Percoll gradients as described 
above. 14C content of fractions was determined in a scintillation 
counter. The tyrosinase inhibitor phenylthiourea (PTU) was in-
cluded during the labeling of control cell cultures at a concentration 
of 0.25 mM, which we determined to inhibit cellular tyrosinase 
activity by 90-95%. 
Immunofluorescence Microscopy B16 and Cloudman S91 
cells were plated on covers lips for up to 48 h, rinsed in PBS, and 
fixed for 30 min in PBS containing 3% paraformaldehyde and 
0.02% glutaraldehyde, followed by three rinses in PBS. Cells were 
permeabilized by immersion in acetone at - 20 ° C for 15 sec, rinsed 
in PBS, and exposed to eitheraLAMP-l oraPEP-l for 1 h at 37°C. 
Excess antibody was removed from the cells by rinsing five times in 
PBS prior to exposure to Texas-red labeled anti-rat Ig or FITC-la-
beled anti-rabbit IgG (Amersham, or E-Y Labs, San Mateo, CA) for 
1 h at 37°C. Unbound antibody was removed by washing the cells 
five times in PBS. Antibody specificity and background were 
checked by labeling parallel cultures with only FITC or Texas Red-
labeled Ig. Covers lips were mounted with Eukitt non-fluorescent 
medium (Calibrated Instruments, Ardsley, NY). Observations were 
made with a Zeiss standard microscope equipped with phase, inter-
ference, and fluorescence optics using fi lter system (G546, FT580, 
LP590) for Texas Red and filter system (G365, FT395, LP420) for 
FITC. Cultures were photographed with Kodak Gold 1600 or 
Kodak T-MAX film. 
Electron Microscopy/ Immunocytochemistry Melanoma 
cells were seeded into Lab Tek chamber slides (Nunc, Inc., Naper-
ville, IL), allowed to proliferate to confluency, and subsequently 
embedded in Lowicryl K4M as follows [33]. Cells were washed 
twice in PBS and fixed with 4% paraformaldehyde, 1 % glutaralde-
hyde, and 0.2% picric acid in 0.1 M phosphate buffer containing 
0.5 mM calcium chloride (pH 7.4) for 20 min at room temperature. 
Cells were then washed three times and incubated in 0.25% tannic 
acid for 10 min at room temperature. Cells were washed three 
times, quenched in 50 mM ammonium chloride for 20 minutes at 
O°C, washed four times in 0.1 M maleate buffer (pH 6.5), and 
treated with 2% uranyl acetate (pH 4.0) for 30 min at O°c. Cells 
were dehydrated with acetone, infiltrated with Lowicryl K 4 M at 
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-20°C and the embedding medium polymerized under UV irra-
diation at -20°C for 2 d. 
Embedded cells were mounted on epoxy pegs and sectioned on a 
RMC MT 6000-XL ultramicrotome. Sections were placed o.n 
nickel grids and processed for immunolabeling as follows: specI-
mens were washed with 50 ruM Tris containing 150 mM sodium 
chloride at pH 7.4 (TBS) and blocked with 1% BSA in TBS con-
taining 0.0.2% Tween 20 (TBS-ICC) for 10 min. Specimens were 
treated with the primary antisera diluted in TBS-ICC for 2 h at 
room temperature and subsequently washed extensively. Primary 
antisera consisted of aPEP-l, aPEP-2, or normal rabbit serum (all at 
1: 100-1 : 200), or aLAMP-l (at 1: 5 -1: 10). In the case of 
LAMP-l staining, a bridging antibody consisting of rabbit anti-rat 
IgG at 1: 100 was used. Washed specimens were incubated with 
Protein A conjugated to either 5-nm or 18-nm diameter colloidal 
gold particles (diluted 1: 10 in TBS) for 1 h at room temperature. 
Specimens were washed extensively, stabilized with 2% glutaralde-
hyde for 5 min and stained sequentially with 2% osmium tetroxide 
for 15 min and Reynold's lead citrate for 3 min. Specimens were 
then washed, dried, coated with Formvar, viewed, and photo-
graphed in a JEOL JEM-l 00 ex transmission EM. 
RESULTS 
Subcellular Distribution of Tyrosinase The subcellular distri-
bution of tyrosinase was examined in B 16 (wild-type) cells cultured 
under various conditions that induce differing degrees of melaniza-
tion. When the post nuclear supernatants from B 16 cells were frac-
tionated on Percoll density gradients, three peaks of tyrosinase actiV-
ity could be ide~tified, th~ relative ratios of which were dependent 
on the state of pIgmentation of the cell. When unstimulated, non-
pigme~ted B16 cells were analyzed, two peaks of tyrosinase activ-
lty, deSIgnated peak I and peak II, were noted, with Peak I, the less 
dense peak, predominating (Fig lA) . If, instead, B16 cells induced 
to melanize lightly by growth for 3 d in synthetic AIM V medium 
[28] were subjected to similar analysis, the denser peak, peak II, was 
noted to be the predoml11ant one, with a concomitant diminution in 
Peak I (Fig 1~). Whe~ B 16 cells were cultured for 10 d in synthetiC 
AIM V medlUm, whIch greatly stimulates melanin production by 
these cells [28]' a.n~ subsequently analyzed, only a small proportion 
of tyrosmase actIVIty was present in peaks I and II. A very dense 
peak, .peak III, was prominent (Fig lC). 
Thl~ dense peak ~oincided with the presence of readily visible 
melanm on the gradIent (not shown) , suggesting that it represented 
stage !I.I - I.V melanoso~es, as these are the sole sites of pigment 
depOSItIOn m melanocytic cells. Melanin could not be detected visu-
~ly ~r spectrophotometricaUy in peaks I and II. To confirm the 
~dentlty of peak I~I with the site of actual melanin deposition, cells 
mduced to melamze by culture in AIM V medium were incubated 
overni.ght in the presence of 14C DOPA, which is incorporated into 
melanll1 subsequent to oxidation by tyrosinase. When the postnu-
clear supernatants of these cells were subjected to Percoll gradient 
analy~is, the ~~.or peak o~ 14C incorporation coincided with peak 
III (~lg 2~. !hls mcorporatlOll was entirely dependent on the enzy-
~a~lc aCtiVIty of ryrosinase, b.ecause inclusion of the tyrosinase in-
~lb~t~r PTU .durll1g th~ pel'lod of metabolic labeling effectively 
1I1lublted the lI1corporation of 14C DOPA into peak III (Fig 2). 
Thu~, peaks I: II, and III as detected on Percoll gradients delineate 
succeSSIve ~teps m melanosomalmaturation; their relative presences 
could be dl~e~~ly correlated with increasing melanization. Because 
of the pOSSlblhty that the activity of tyrosinase did not accurately 
reflect the presence of the protein itself, we also determined the 
dist~ibution of i~mun~reactive tyrosinase protein on the gradient 
by lmmunobl.ottmg uSlllg. ~PEP-7, an antiserum specific for the 
carboxy-termmus of tyroslllase [29]. The results of this analysis 
demonstrated that the enzYlllatic ~ctivity of tyrosinase was paral-
leled by the prese~ce o~ the protem (not shown). (We routinely 
observe~ that tyrosmase m peak III appeared more active than when 
present m peaks I and II, based on the ratio of activity: protein 
present on Western blot.) 
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Figure 4. Immunofluorescent ana!ysis of the distribution ofTRP-1 (A) and ~AMP-1 (B) in B 16 cell.s. The similarity in distribution is most remarkable in 
relatively large granular structures m the permuclear area (arrow). (C) Phase microscopy. (D) Double-Immunofluorescent stammg for TRP-1 and LAMP-1. 
Areas of colocalization appear yellow due to the overlap ofTRP-1 (red) and LAMP- l (greet/). Note the large spherical organelles that demonstrate a green 
center but a strongly fluorescent yellow periphery. Bars: A - C, 14 Ii; D, 7 )1.. 
The Subcellular Distribution ofTRP-l Overlaps but is Dis-
tinct From. That of Tyrosinase Having established the subcel-
lular distribution of tyrosinase, we next analyzed the distribution of 
TRP-l, again using a specific antipeptide antiserum (aPEP-l) di-
rected against the protein's carboxy terminus, which does not cross-
react with tyrosinase [29,34]. The results of this analysis are de-
picted in Fig lA - C. The distribution of TRP-1 overlapped with 
but did not parallel that of tyrosinase, and, unlike the distribution of 
tyrosinase, was relatively independent of cellular pigmentation. 
The majority of TRP-l colocalized with peak I, whereas a small 
fraction could be detected in peak II. Under no circumstances was 
TRP-l found in peak III. Thus, although tyrosinase was present to 
different extents in peaks I - III, the highest levels of tyrosinase 
always accumulated in the most "mature" melanosomal compart-
ment available. In contrast, the localization ofTRP-l was limited to 
the lightest peak, peak I and, to a lesser extent to peak II, even in the 
most deeply pigmented cells. 
Similar results were obtained when darkly pigmented B16 cells 
were analyzed with two other antibodies directed against TRP-l, a 
second antipeptide antibody directed against an amino-terminal 
epitope (aPEP-2) [29] , and a rat monoclonal antibody also recogniz-
ing the intraluminal portion of TRP-l (TMH-l ; [35]) (data not 
shown). Thus, the absence ofTRP-l from the "later" melanosomal 
compartment could not be explained merely by the selective loss of 
the carboxy-terminal portion of the protein (e.g., through limited 
proteolysis). 
Subcellular Distribution ofLAMP-l Because of the suspected 
relationship between melanosomes and lysosomes, we also deter-
mined the distribution on these gradients ofLAMP-l, a marker for 
organell~s ~f th.e endosomal/lysosomallineage [21]. 
The dlstnbutlon of LAMP-l paralleled that ofTRP-1 in all cases 
(Figs lA-C). Its presence was generally limited to peak I and, to a 
les~er e~tent, to peak II, re~ar~fles~ of the exte.nt of cellular pigmen-
ta~lOn, m contrast to the dlstnbutlon of tyrosmase activity and pro-
tem. 
Because it was possible that the cosedimentation ofLAMP-l and 
TRP-l on the gradients was a function of their localization in dif-
ferent organelles of similar density, we carried out the immunoiso-
lati?n ofTRP-l - containing organe lles using antibody-coated mag-
netic beads. The PEP-1 epitope is believed to be located on the 
cytoplas~c side of the men~branes i.nto. which it is inserted [6,29] 
and th.us .It should be acceSSible to bllldmg to the antibody-coated 
beads m mtact organelles. As controls, we used beads coated with 
normal rabbit serum and with antibodies to PEP-2, which is located 
at the amino-terminal and presumably intraluminal portion of 
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Figure 5. (a) Ultrastructure of routinely processed B16 melanoma cell demonstrating Golgi apparatus (G), a neighboring large, electron-lucent vacuole 
(asterisk), a stage I meianosome (arrowhead) , and a stage II melanosome (arrow). Bar, 0.5 j.tm. b-g) Ultr.astructural immunolocalizatioll ofTRP-l and LAMP-1. I 
in B16 melanoma cells (genotype BIB). TRP-l Immunoprobed with aPEP-l (b,c), winch recogl1lzes Its carboxy-terminus, is associated with the Goigi 
apparatus (G) and nearby electron-lucent vacuoles (asterisks). The PEP-I-associated gold particles are predominately on the cytoplasmic side or on the 
membranes of the Golgi apparatus (small arrowheads) and the electron-lucent vacuoles (large arrowheads). TRP-l immunoprobed with PEP-2 (d,e), which 
recognizes its amino terminus, also demonstrates its presence in (d) the Goigi apparatus (G) and (e) electron-lucent vacuoles (asterisks) in the Golgi area. 
PEP-2-associated gold particles are in this case predominantly within the Golgi cisterna (small arrowheads) or lumen of the vacuoles (large arrowheads). 
LAMP-IJ,g) localized to the electron-lucent vacuoles (asterisks) and some stage I premelanosomes (arrowheads), but was absent from melanosomes containing a 
matrix or melanin (arrows). (A) Autophagosome containing numerous melanosomes, which is LAMP-l positive. Bars: b,c,g = 0.23 j.t; d = 0.15 j.t; eJ = 0.31 IL. 
TRP-1 [6,29]. The results in Fig 3 demonstrate that organelles 
bearing the PEP-1 epitope on their surface contain LAMP-1, verify-
ing that the two proteins are present within the same organelle. 
Neither TRP-lnor LAMP-l were immunoisolated by beads coated 
with NR5 or aPEP-2. 
ImmUDomicroscopy We confirmed these results by immuno-
fluorescent and immunoelectron microscopy. Immunofluorescent 
analysis with aPEP-l and aLAMP-1 was carried out on cultured 
B16 cell s (Fig 4). In the perinuclear region, aPEP-1 recognized 
large vacuolar structures with intense staining of their delimiting 
membranes. Numerous smaller granules that stained brightly with 
aPEP-l were evenly distributed throughout the cytoplasm and in 
cellular dendritic extensions. Whereas LAMP-l was present in a 
number of distinct vacuolar structures, the large perinuclear organ-
elles with aPEP-1-positive membranes showed intense staining of 
their luminal aspects by aLAMP-l. 
Immunoelectron microscopy confirmed these observations. 
TRP-l (via aPEP-l and aPEP-2) and LAMP-l (via aLAMP-l) 
were immunolocalized ultrastructurally in B 16 cells (Fig 5). TRP-1 
was present on cisternal membranes of the Golgi apparatus (Figs 
5h,d) and in large vacuoles within the Golgi area (Figs 5e,e). These 
latter stmctures also contained LAMP-l (Fig 5j), whereas melano-
somes were r~latively negative for LAMP-l (Fig 5g). The trans-
membrane onentatlon of TRP-l, formerly inferred exclusively 
from its predicted amino acid sequence [6,29], in which the PEP-1 
epitope is on the cytoplasmic side and the PEP-2 epitope is on the 
luminal side, was confirmed by immunoelectron microscopy (Fig 
5). Gold particles associated with aPEP-1 labeling were predomi-
nantly localized at the cytoplasmic side of the limiting membranes 
of the Golgi cisternae and the positively staining organelles (Figs 
5b,e). In constrast, gold particles associated with aPEP-2 labeling 
were within the lumen of the Golgi cisternae and positively-stain-
ing organelles (Fig 5dl e). 
Effects of the Brown Mutation We next determined the effects 
of ~he homozy~ous rec~ssive brown mutation (resulting in twO 
ammo aCid substltutlOns 111 TRP-l (36]) in cultured Cloudman S91 
melanoma cel ls that bear this mutation (genotype bib). 
TRP-l from bib cells is more rapidly degraded and its distribution 
more restricted than in wild-type cells. In contrast to B 16 cells, the 
Mr ofTRP-l in Cloudman 591 cells detected by immunoblotting is 
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Figure 6. (A) Immunoblotting analysis: B 16 cells contai~ a 75-kd form of 
TRP-1, whereas in Cloud man S91 cells the molecular weight of TRP-1 IS 
only 68 kd. The right IOlle in each pair shows cells pr~treated with MSH/ 
IBMX. No change in the quantity ofTRP-1 IS seen 111 B16 cells. On.ly a 
small increase is noted in S91 cells in agreement with previous reports [46]. 
(B) Pulse-chase analysis of TRP-1 synthesis in B16 (BjB) and Clolldn~an 
S91 (bib) cells. Metabolic labeling and ImmunopreclP.ltatlon were earned 
out as described in Materials alld Methods. Note that while 111 B16 cells (lift) 
TRP-1 is processed to the mature 75-kd form, in Cloud man S91 cells (right) 
the protein is instead slowly degraded without progressing beyond the 68-kd 
form. (C) Treatment with inhibitors of protein glycosylatlon. When N-
linked glycosylation is inhibited by tllnicamycin, both B16 (lift) and Cloud-
man cells (right) synthesize a 55-kd form ofTRP-1. Treatment With swalJ1-
sonine (S) and deoxymannojirimycin (D), inhibitors of later steps in 
N-linked glycoprotein processing, results in the appearance of a 68-kd dou-
blet in B16 cells. Little or no change in the Mr of the 68-kd form in 
Cloud man S91 cells was observed. 
68 kd (Fig 6A). In metabolic labeling studies, pulse-chase analysis of 
B 16 (BIB) ce lls demonstrated that TRP-1 at the earliest timepoint 
analyzed migrated with an apparent Mr of 68,000, and was slowly 
processed to a final Mr of 75,000. The half-life of the protein was 
greater than 5 h (Fig 6B,C). In cont~ast, in S91 cells (bib) . the 
protein remained as the Mr 68,000 speCies, ~nd was de~raded ~Ith a . 
half-life of about 2 h (Figs 6B,C). InclUSIOn of tumcamycl11 (an 
inhibitor of N-linked glycosylation) in metabolic labeling experi-
mentS resul ted in the immunoprecipitation of a 55,000-Mr species 
from both cells, in agreement with the results of other investigators 
[18,20]. Deoxymannojirimycin and swainsonine, inhibitors oflater 
stages of glycoprotein processing, blocked processing of TRP-1 in 
B 16 cells at the 68-kd form. N either inhibitor affected the Mr of the 
68-kd form ofTRP-1 in C loudman cells, suggesting that the glyco-
sylation ofTRP-1 in bib cells is incomplete . 
When Cloudman S91 cells induced to melanize with the combi-
nation ofMSH/IBMX were subjected to Percoll gradient fractiona-
tion, we found that tyrosinase was distributed in Peaks I - III, similar 
to its distribution in B 16 cells (Fig 7). However, two important 
differences were noted. The first was that the distribution ofTRP-1 
was even more limited than it was in B16 cells and appeared to be 
absolutely restricted to Peak 1. The second, even more surprising, 
result was that, in contrast to B 16 cells, Peak III from pigmented 
S91 cells was rich in LAMP-1 (Fig 7). Possible explanations for this 
observation are detailed in the DisCIIssioll section. 
Immunofluorescent labeling of S91 cells demonstrated that 
TRP-1-positive granules were main ly perinuclear (Fig 8). Some 
fine granules were found in the cytopl.asl11 and in dendrites. ~9.1 cells 
exhibited an extensive TRP-I-posltlve and LAMP-I-pOSItIve re-
ticular network, not presen t in B 16 cells, that radiated from the 
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center of the cell. Larger LAMP-1- positive vacuoles, like those 
seen in B16 cells, were also found in this location, and again as in 
B16 cells, only certain of these contained TRP-1. As in B16, a high 
concentration ofLAMP-1 fluorescence was also found at the tips of 
dendrites. These regions did not overlap with TRP-1. 
TRP-1 (via aPEP-1) was localized ultrastructurally in S91 cells to 
large vacuoles without apparent melanofilaments (Fig 9a). LAMP-l 
was also localized to these structures, as in B16 cells, but unlike in 
B 16 cells was also present within melanosomes containing a matrix 
(Fig 9b). The presence of melanin within melanosomes made it 
difficult to determine whether heavily melanized organelles were 
truly positive or negative for LAMP-l by the techniques we em-
ployed. 
DISCUSSION 
By using . hormon~1 and pharmacologic means to manipulate the 
state of pigmentation and melanosomal "maturation" within cul-
tured murine melanoma cells of defined genotype, we have identi-
fied premelanosomal and mature, melanized melanosomal com-
partm~nts. W.it~ increasing cellular. pigmentation, a peak of 
melamn-contallllllg granules appears III subcellular fractionation 
studies, which is accompanied by the presence of tyrosinase activity 
and immunoreactive protein. Surprisingly, however, we have found 
that TRP-1, which has been widely assumed to parallel tyrosinase in 
its d.is~ribution based on .similarities in its amino acid sequence [18-
20] IS III fact largely restncted to the early unmelanized melanogenic 
compartment (stage I and II melanosomes). 
Because Stage II unmelanized melanosomes are distributed 
throughout the cytoplasm, it is understandable that previous 
studies, which employed single-label immunofluorescent analysis, 
imputed a melanosomal distribution to TRP-l based on its presence 
in cytoplasmic granules [19]. Our results are consistent with those 
previously reported in that TRP-1 is indeed present in the cyto-
plasmic Stage I and Stage II melanosomes, but we could not 
detect TRP-1 in stage III - IV melanosomes. By contrast, in pig-
mented cells, tyrosinase is present primarily in stage III - IV melano-
somes. 
The primary amino acid sequences of~oth tyrosinase and TRP-l, 
as ~educed from the cloned genes, cont~l~ a stretch of hydrophobic 
am1l10 aCids close to the carboxy term1l11 of both proteins, which 
represent a putative transmembrane region [34]. It has been pro-
posed that both molecules are thus type-1 membrane proteins of the 
melanosome, oriented with the carboxy-terminus extending into 
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Figure 7. Subcellular distribution of tyrosinase, TRP-l, and LAMP-l in 
pigmented Cloud man S91 cells (genotype bib) . Procedures were identical to 
those used in Fig 1. Note that TRP-1 is limited to peak J, but (in contrast to 
B 16 cells) LAMP-1 is found in peak III (sec text). 
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Figure 8. Immunofluorescent analysis of the distributio~ of TRP-1 (A) 
and LAMP-1 (B) in Cloud man S91 cells. A.n extensive reticular network is 
evident in both cases (arrow). (C) Phase nucroscopy-. Bar, 14/1. 
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the cytosol and the amino-terminus extending into the lumen of the 
melanosome. We have reported two independent experiments, the 
immunoisolation of cellular organelles using aPEP-1-coated mag-
netic beads and the distinct immuno~lectron n:icrosc?pic l.ocal.iza-
tion of the PEP-1 versus the PEP-2 epltope, which verity thiS onen-
tation. 
The amino acid sequences of tyrosinase and TRP-1 are 43% iden-
tical, with conservation of histidi~e residues implicated in copper 
binding and cysteine residues believed to form disulfide bonds, .b~t 
there are extended sequences, especially at their carboxy-termiru, In 
which the two proteins differ significantly [14,15]. Because both 
tyrosinase and TRP-1 are Type-1 membrane proteins with short 
cytoplasmic carboxy-terminal tails and long intraluminal glycosyl-
ated portions, it is tempting to speculate that the intracellular S?rt-
ing of these proteins is dictated by the cytoplasmic carboxy-tennJ.nal 
sequences, as is the case for two other type-l membrane protetnS, 
LAMP-l and lysosomal acid phosphatase [37,38]. 
Our data also suggest that the early melanosomal compartment, 
perinuclear in distribution, contains both TRP-1 and LAMP-1. 
LAMP-1 is a marker for organelles of the endosomal-Iysosomal 
lineage, although it may also be present in certain secretory granules 
that derive from the trans-Golgi network [21]. The presence of 
LAMP-1 in late endosomes is particularly interesting, as it is one 
piece of a large body of evidence that established the endosome ~ 
the point of convergence of the endocytic and lysosomal biogenetiC 
pathways [39-41]. 
The size, shape, and perinuclear distribution of the LAMP-l-
positive, TRP-1- positive, unmelanized melanosomal compart-
ment we have identified are consistent with those of a late endo-
some [21]. Support for this hypothesis comes from a recent report 
that when an expression vector encoding TRP-l is transfected into 
fibroblasts (which lack melanosomes), the TRP-1 produced local-
izes to large perinuclear vacuoles that also containp-glucuronidas~, 
a late endosomal-lysosomal marker enzyme [42]. Further expen-
mentation will be required to test this hypothesis; nonetheless, our 
data provide biochemical, immunologic, histologic, and ultrastruC-
tural evidence in support of the long-suspected relationship be-
tween the melanosome and organelles of the lysosomal lineage. 
Such a relationship can be inferred from the existence of a number 
of mutations affecting both humans and laboratory mice. swank 
and colleagues [24] have identified at least ten autosomal recessive 
mutations in the mouse that affect coat color and ocular pigmenta-
tion, as well as the secretion of kidney lysosomal hydrolases. Indeed, 
one such mutation, beige, is the homologue of the human disorder 
Chediak-Higashi syndrome [43]. Affected individuals are charac-
terized by hypopigmentation, whereas microscopic examination 
reveals the presence not only of giant melanosomes but also of giant 
lysosomal or lysosomally derived granules in nomnelanocytic tis-
sues [44]. 
The brown mutation in mice results in the production of brown, 
rather than black, melanin [45], which is soluble at physiologic pH 
[17]. Of the two amino acid substitutions caused by the brown 
mutation, only one is critical [36]. Electron microscopic investiga-
tion has revealed that brown melanosomes are more spherical than 
their black counterrarts, and the melanin within them is more floc-
culently deposited 16]. Our results suggest that a molecular corre-
late of the brown mutation is the incomplete glycosylation and rapid 
degradation ofTRP-1. Because neither of the two amino acid sub-
stitutions alter potential glycosylation sites [36], the altered glyco-
sylation we observed might be best explained by aberrant folding of 
TRP-1, resulting in the normally. glycosylated sites remaining un-
recognized or inaccessible. We do not yet know if the apparent 
presence ofLAMP-1 in melanized melanosomes is due to the failure 
of LAMP-l to be excluded from the maturing me1anosome or 
whether in brown mice mature me1anosomes, devoid of LAMP-1, 
may fuse with lysosomes or other LAMP-1- positive organelles to 
form a LAMP-I-positive structure containing melanin (e.g., auto-
phagocytosis or crinophagy). Further experimentation will be re-
quired to differentiate between these two possibilities. 
Taken together, our results suggest that following their process-
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P ' e 9 Ultrastructural immunolocalization ofTRP-l and LAMP-l in Cloudman S91 melanoma cells. TRP-l immunoprobed with aPEP-l (a) demon-l~~ lo~alization predominantly on the membrane of the larger, electron-lucent vacuoles (asterisks) and minimally on or absent from melanosomes with 
:r:t: ix (arrows) and melanin (arrowh eads). (b) LAMP-l is also localized to the electron-lucent vacuoles (asterisks) but the presence of LAMP-l in melanosomes 
with matrix (arrows) as well as in some melanized melanosomes was repeatedly noted. Bar, 0.2 J.l. 
ing in the Golgi and TGN, tyrosinase and TRP-.l enter a LAM.P-l -
positive organelle of a nature yet to be determined, but consistent 
with a late endosome. Stage III and IV melanosomes are sites of 
accumulation of both melanin and tyrosinase, but lack immuno-
logically identifiable TRP-1. Whether the absence of TRP-l 
from Stage III melanosomes is due to its specific retention in less, 
mature melanosomes, reshuttling back to these organelles, or to 
degradation within stage. ~I.- I~I melanosomes, remains to ~e 
determined. A fourth posslblhty IS that TRP-l becomes encased III 
or is made insoluble by melanin deposited in stage III-IV melano-
somes and that the same fate does not befall tyrosinase (to the same 
extent) . 
Our data form a framework by which to begin to understand 
melanolysosomal disorders such as Chediak-Higashi syndrome 
and the H ermansky-Pudlak syndrome at a molecular level. The 
presence of a post-Golgi organelle that contains both LAMP-l .. a 
marker for the lysosomal lineage of organelles, as well as proteins 
such as TRP-l, which playa role in melanogenesis, identifies a 
commonality between melanosomes and lysosomes and suggests a 
mechanism by which a single mutation could affect both of these 
organelles. . . . . 
Finally, we have recently shown that melanins nch 111 dlhydrox-
yindole-2-carboxylic acid, while soluble at"pH 7, become p.rogre.s-
sively insoluble as the pH is lowered to 5 l17]. If the reiatlOnslup 
between melanosomes and Iysosomes extends to the presence of an 
apparatus for the progressive acidification of the intra.organellar 
milieu, as has been suggested [47,48], then the adaptation by the 
melanocyte of a preexisting lysosomal design may have important 
implications for the means by which melanin is physically deposited 
within the melanosome. 
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